rs145337558
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001130965.3(SUN1):c.1861G>A(p.Gly621Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G621G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001130965.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SUN1 | NM_001130965.3 | c.1861G>A | p.Gly621Ser | missense_variant | 15/19 | ENST00000401592.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SUN1 | ENST00000401592.6 | c.1861G>A | p.Gly621Ser | missense_variant | 15/19 | 1 | NM_001130965.3 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.000401 AC: 61AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000841 AC: 21AN: 249580Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135406
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461870Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727236
GnomAD4 genome ? AF: 0.000400 AC: 61AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.1861G>A (p.G621S) alteration is located in exon 15 (coding exon 15) of the SUN1 gene. This alteration results from a G to A substitution at nucleotide position 1861, causing the glycine (G) at amino acid position 621 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Emery-Dreifuss muscular dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 14, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 621 of the SUN1 protein (p.Gly621Ser). This variant is present in population databases (rs145337558, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SUN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 530827). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at